제이에스링크
127120KOSDAQ자연과학 및 공학 연구개발업54.5 / 100
Reference Date: 2026-07-24
Company InformationBased on 2025 Annual Report
Business Overview
JS Link operates in genomics analysis, personalized medicine, and diagnostics, leveraging advancements in genomic technology and rising demand for customized treatments. As genome sequencing costs have drastically decreased and bioinformatics becomes crucial for handling large data, the molecular diagnostics market is rapidly expanding. Establishing Asia-specific genomic databases is key to securing global competitiveness.
Number of Employees
139people
Average Salary
53.5M KRW
Score Calculation Basis
Detailed Financial Score
7.0x industry avg (risky)
In line with industry avg
Higher than industry avg (caution)
Avg ▼3.0% (2-year basis)
Avg ▼73.4% (2-year basis)
Avg ROE -32.6% (declining, 3yr)
Detailed News Sentiment
- Positive제이에스링크, 534억원 유상증자 추진…영구자석 투자 확대
제이에스링크의 대규모 유상증자로 영구자석 사업 확장 계획이 구체화되어 긍정적인 시장 반응을 예상.
- Neutral제이에스링크, 534억 규모 제3자배정 유상증자 결정
제이에스링크의 유상증자 결정으로 자금 조달 계획이 발표되었으나, 직접적인 시장 영향은 제한적임.
Detailed Momentum
52w upper range (60%)
1m -0.57% (flat)
Volume flat
Detailed Disclosure
- Positive[기재정정]주요사항보고서(유상증자결정)2026-07-21
- Positive[기재정정]주요사항보고서(유상증자결정)2026-07-15
- Positive주요사항보고서(유상증자결정)2026-07-07
- Neutral기업설명회(IR)개최2026-07-07
- Neutral주식등의대량보유상황보고서(약식)2026-07-01
